Tarsus Pharmaceuticals, Inc. TARS Event-Based Development Milestone — Contractual milestone payment net sales
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept tars:CollaborativeArrangementRightsAndObligationsContractualMilestoneNetSales.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s event-based development milestone — contractual milestone payment net sales.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s event-based development milestone — contractual milestone payment net sales?
- Tarsus Pharmaceuticals, Inc. (TARS) reported event-based development milestone — contractual milestone payment net sales of $3M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s event-based development milestone — contractual milestone payment net sales changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s event-based development milestone — contractual milestone payment net sales decreased by 0.0% year-over-year, from $3M to $3M.
- What does event-based development milestone — contractual milestone payment net sales mean?
- This metric represents revenue recognized from contractual milestone payments triggered by the achievement of specific development or regulatory events within a product segment. It reflects the successful attainment of predefined clinical or commercial objectives that unlock non-recurring financial compensation under licensing or collaboration agreements. Monitoring this metric helps investors assess the progress of the company's pipeline and the realization of value from strategic partnerships.